DEDHAM, Mass., January 27, 2026--(BUSINESS WIRE)--Qlaris Bio, Inc., a clinical-stage biotechnology company focused on developing first-in-class therapies for glaucoma, today announced the appointment ...
Weave Bio, the leader in AI-native regulatory automation, today announced the formation of its inaugural Strategic Advisory Board (SAB). Bringing together senior executives and thought leaders with ...
Vor Bio, a clinical-stage cell and genome engineering company, has appointed Mr. Erez Kalir to its Board of Directors, creating a new seat following a recent private investment in public equity (PIPE) ...
Vor Bio (VOR) announced the appointment of Erez Kalir to its Board of Directors. The appointment represents a new seat on Vor Bio’s Board of Directors, which has been created in connection with the ...
MALVERN, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- MALVERN, Pa., November 3, 2025 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA Bio”) (NASDAQ: TELA), a commercial-stage ...
John Crowley, the longtime leader of rare disease drug developer Amicus Therapeutics and a board member of the Biotechnology Innovation Organization, will become the trade organization’s new president ...
New Chair brings extensive financial and life sciences experience with industry-leading companies SOUTH SAN FRANCISCO, Calif., March 17, 2022 /PRNewswire/ -- Mission Bio, Inc., the pioneer in ...
DURHAM, N.C.--(BUSINESS WIRE)--Oerth Bio (pronounced “Earth”), an agricultural biotech company pioneering targeted protein modulation for plant health applications, has appointed Thong Q. Le as an ...